Vimarsana
Biggest News Aggregation in the World

Page 17 - Aptar Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Aptar Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Aptar Pharma Today - Breaking & Trending Today

2,602 Shares in AptarGroup, Inc. (NYSE:ATR) Acquired by Sciencast Management LP - Vimarsana News

2,602 Shares in AptarGroup, Inc. (NYSE:ATR) Acquired by Sciencast Management LP

Sciencast Management LP purchased a new stake in AptarGroup, Inc. (NYSE:ATR – Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 2,602 shares of the industrial products company’s stock, valued at approximately $298,000. Other institutional investors also recently modified their holdings […]

FDA rejects neffy epinephrine nasal spray for severe allergic reactions pending further trial data - Vimarsana News

FDA rejects neffy epinephrine nasal spray for severe allergic reactions pending further trial data

ASR Pharma said it was surprised and "deeply disappointed" by the FDA request for more trial data on its neffy nasal spray for severe allergic reactions.

AptarGroup, Inc. (NYSE:ATR) Sees Large Increase in Short Interest - Vimarsana News

AptarGroup, Inc. (NYSE:ATR) Sees Large Increase in Short Interest

AptarGroup, Inc. (NYSE:ATR – Get Free Report) saw a significant growth in short interest during the month of August. As of August 31st, there was short interest totalling 563,400 shares, a growth of 10.7% from the August 15th total of 508,800 shares. Currently, 0.9% of the company’s shares are short sold. Based on an average […]

CPHI Barcelona announces Pharma Award finalists - Vimarsana News

CPHI Barcelona announces Pharma Award finalists

CPHI Barcelona announces the finalists for the upcoming CPHI Pharma Awards, which will be hosted on the opening day (24th October, 2023) of the world’s largest pharma event at the Fiera Barcelona. The shortlist was whittled down from more than 180 entries across 12 categories. Innovations cover the full ...

From Digital Platforms to Aging Demographics: Key Drivers in the Respiratory Inhalers Market - Vimarsana News

From Digital Platforms to Aging Demographics: Key Drivers in the Respiratory Inhalers Market

/PRNewswire/ -- The "Respiratory Inhalers Market Report 2023-2033" has been added to ResearchAndMarkets.com's offering. With an eye on global revenue, the...